The European Commission has proposed rules to control the use of bovine, ovine and caprine material in the manufacture of medicinal products that, if passed, could have wide-ranging consequences for the production of pharmaceuticals

The measures are designed to prevent the spread of transmissible spongiform encephalopathy (TSE) and bovine spongiform encephalopathy (BSE, or "mad cow disease"). The proposal is scheduled to be discussed at the end of the month,